Jefferies upgraded its rating to buy from hold, while Truist boosted its price target and RBC upped its target price for AdaptHealth.
3 reports, 2 independent
Updated Jul 28
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies upgraded its rating to buy from hold, while Truist boosted its price target and RBC upped its target price for AdaptHealth.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AdaptHealth
health care services
Nothing else this week.
-
Jefferies Financial Group
American financial services company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
-
Royal Bank of Canada
financial institution in Canada
Related events
- Financial firms including Truist, RBC, TD Cowen, and Jefferies issued various rating updates on October 30, 2026.
- Analyst firms Jefferies, TD Cowen, and Raymond James Financial provided rating updates for Black Diamond Therapeutics, alongside MarketBeat consensus data.
- MarketBeat reported the stock's average rating as Benchmark and Jefferies reiterated buy ratings for Bright Minds Biosciences Inc.
- BHC received a 'hold' rating from Jefferies, while MarketBeat provided consensus data and the board initiated a stock buyback plan.
- Jefferies Financial Group reiterated a buy rating on Constellation Software stock.
Coverage
Newest first; wire copies grouped- themarketsdaily.comEnterprise Products Partners (NYSE:EPD) Trading Up 1.4% – Still a Buy?
- tickerreport.com